Connect Biopharma Holdings Ltd. Revenue 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Connect Biopharma Holdings Ltd. revenue for the quarter ending March 31, 2026 was 169000.
- Connect Biopharma Holdings Ltd. revenue for the twelve months ending March 31, 2026 was 233000.
- Connect Biopharma Holdings Ltd. annual revenue for 2025 was 64000, a 99.75% decrease from 2024.
- Connect Biopharma Holdings Ltd. annual revenue for 2024 was 26.0 M.
- Connect Biopharma Holdings Ltd. annual revenue for 2023 was 0.
Connect Biopharma Holdings Ltd. (CNTB) — Frequently Asked Questions
Connect Biopharma Holdings Ltd. (CNTB) is a publicly traded US company. It has a market capitalization of $116M. In fiscal 2025 it reported revenue of $64,000 and net income of -$55M. Explore CNTB's stock price, financial statements, earnings history, margins and key ratios below.
What is Connect Biopharma Holdings Ltd.'s market cap?
Connect Biopharma Holdings Ltd. (CNTB) has a market capitalization of $116M.
What is the CNTB stock price?
CNTB trades at $2.08 (-1.89% on the day).
How much revenue does Connect Biopharma Holdings Ltd. make?
Connect Biopharma Holdings Ltd. reported revenue of $64,000 in fiscal 2025.
Is CNTB profitable?
In fiscal 2025, Connect Biopharma Holdings Ltd. reported net income of -$55M.